Intranasal medications gain popularity in the ED
Administering medications intranasally as an alternative to I.V.s and injections is becoming more frequent in the ED and out-of-hospital settings, according to a study…
Web Exclusives
Local warming before tourniquet application increases vein size
Applying local warmth before a tourniquet significantly increases venodilation without adverse effects, according to a study in the International Journal of Nursing Studies. Read…
Passive leg-raising may help predict fluid responsiveness
Passive leg-raising helps predict response to fluid administration given to patients in shock, according to a study in Critical Care Nurse. Read more
FDA approves first drug for tardive dyskinesia
On April 11, the U.S. Food and Drug Administration (FDA) approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. It’s the first drug…
Rise in chronic venous insufficiency procedures
The use of procedures to treat chronic venous insufficiency in Medicare patients increased markedly from 2005 through 2014, according to a study in Journal…
FDA approves hepatitis C drugs for pediatric patients
On April 7, the U.S. Food and Drug Administration (FDA) approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis…
FDA allows marketing of consumer genetic tests
On April 6, the U.S. Food and Drug Administration (FDA) announced it was allowing marketing of 23andMe Personal Genome Service Genetic Health Risk (GHR)…
Yoga may ease side effects of prostate cancer treatment
For men with prostate cancer, structured yoga class twice a week during radiation treatment reduces fatigue and urinary and sexual dysfunction, according to a…
Health promotion and disease prevention in rural communities
As healthcare professionals, nurses focus on preventing disease and reducing the risk of exacerbation in patients with chronic disease, which decreases the rate of…
The 5As model for smoking cessation
Key takeaways Tobacco use continues to be a leading preventable cause of death. Healthcare professionals can make a positive impact on smoking cessation through…
FDA approves new drug for eczema
On March 28, the U.S. Food and Drug Administration (FDA) approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema. Read more
FDA approves new drug for Parkinson’s disease
On March 21, the U.S. Food and Drug Administration (FDA) approved Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson’s disease who…
Intranasal medications gain popularity in the ED
Administering medications intranasally as an alternative to I.V.s and injections is becoming more frequent in the ED and out-of-hospital settings, according to…
Local warming before tourniquet application increases vein size
Applying local warmth before a tourniquet significantly increases venodilation without adverse effects, according to a study in the International Journal of Nursing…
Passive leg-raising may help predict fluid responsiveness
Passive leg-raising helps predict response to fluid administration given to patients in shock, according to a study in Critical Care Nurse. Read…
FDA approves first drug for tardive dyskinesia
On April 11, the U.S. Food and Drug Administration (FDA) approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. It’s the…
Rise in chronic venous insufficiency procedures
The use of procedures to treat chronic venous insufficiency in Medicare patients increased markedly from 2005 through 2014, according to a study…
FDA approves hepatitis C drugs for pediatric patients
On April 7, the U.S. Food and Drug Administration (FDA) approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to…
FDA allows marketing of consumer genetic tests
On April 6, the U.S. Food and Drug Administration (FDA) announced it was allowing marketing of 23andMe Personal Genome Service Genetic Health…
Yoga may ease side effects of prostate cancer treatment
For men with prostate cancer, structured yoga class twice a week during radiation treatment reduces fatigue and urinary and sexual dysfunction, according…
Health promotion and disease prevention in rural communities
As healthcare professionals, nurses focus on preventing disease and reducing the risk of exacerbation in patients with chronic disease, which decreases the…
The 5As model for smoking cessation
Key takeaways Tobacco use continues to be a leading preventable cause of death. Healthcare professionals can make a positive impact on smoking…
FDA approves new drug for eczema
On March 28, the U.S. Food and Drug Administration (FDA) approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema. Read more
FDA approves new drug for Parkinson’s disease
On March 21, the U.S. Food and Drug Administration (FDA) approved Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson’s…
Poll
Preferred way to get content
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.